Seroprevalence of antibodies against sars-cov-2 and risk of covid-19 in navarre, spain, may to july

HIGHLIGHTS

• who: Rapid communication et al. from the o de Salud Pública de Navarra, Pamplona, Spain have published the research: Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July, in the Journal: (JOURNAL) of 29/07/2022
• what: The authors aimed to estimate the seroprevalence of antibodies against the nucleocapsid (N) and the spike (S) proteins of the SARS-CoV-2 in the population of Navarre in May 2022 and evaluated the effect of these antibodies on the risk of SARS-CoV-2 infection thereafter through . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.